Stryker (NYSE:SYK) and PlusTherapeuticsInc . (NASDAQ:PSTV) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

Analyst Recommendations

This is a summary of current ratings and target prices for Stryker and PlusTherapeuticsInc ., as reported by MarketBeat.com.

Stryker currently has a consensus target price of $214.39, suggesting a potential downside of 0.88%. Given Strykers higher probable upside, analysts clearly believe Stryker is more favorable than PlusTherapeuticsInc ..

Volatility and Risk

Stryker has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, PlusTherapeuticsInc . has a beta of 1.83, indicating that its stock price is 83% more volatile than the S&P 500.

Earnings & Valuation

This table compares Stryker and PlusTherapeuticsInc .s revenue, earnings per share and valuation.

Stryker has higher revenue and earnings than PlusTherapeuticsInc ..

Institutional & Insider Ownership

73.0% of Stryker shares are held by institutional investors. 7.2% of Stryker shares are held by insiders. Comparatively, 0.7% of PlusTherapeuticsInc . shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Dividends

Stryker pays an annual dividend of $2.08 per share and has a dividend yield of 1.0%. PlusTherapeuticsInc . does not pay a dividend. Stryker pays out 28.5% of its earnings in the form of a dividend. Stryker has raised its dividend for 8 consecutive years.

Profitability

This table compares Stryker and PlusTherapeuticsInc .s net margins, return on equity and return on assets.

Summary

Stryker beats PlusTherapeuticsInc . on 12 of the 14 factors compared between the two stocks.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 80 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

About PlusTherapeuticsInc .

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in developing treatments for cancer and other diseases in the United States. The company's lead product candidate in pipeline is DocePLUS, an albumin-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer. It also engages in developing DoxoPLUS, an injectable generic PEGylated liposomal formulation of doxorubicin for the treatment of breast, ovarian, multiple myeloma, and Kaposi's sarcoma cancer. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.

View post:

Analyzing PlusTherapeuticsInc . (NASDAQ:PSTV) and Stryker (NASDAQ:SYK) - Riverton Roll